MyStocks

MEMBER'S LOGINX

Remember Username
Keep me signed in

(Please do not use this option on a public machine)

Home
Research It
ALEMBIC LIMITED (pharmaceuticals)
ALEMBIC LIMITED Financial Data

ALEMBIC LTD Fact Sheet (ALMC)

Mail
Print
FaceBook
Twitter
Linked In
WhatsApp

Here is the latest financial fact sheet of ALEMBIC LTD. For more details, see the ALEMBIC LTD quarterly results and ALEMBIC LTD share price and chart. For a sector overview, read our pharmaceuticals sector report.

ALEMBIC LTD Price History

Price	Rs	40.0
Mkt Cap	Rs m	22,124
Vol	'000	14.4
P/E	X	50.1
P/CF	X	48.6
EPS (TTM)	Rs	0.8

% ch	%	0.1
No. of shares	m	553.80
% ch week	%	0.4
% ch 1-mth	%	-8.9
% ch 12-mth	%	-34.0
52 week H/L	Rs	64.0/35.8

(As on Feb 19, 2019 (Close))

» Best Performing pharmaceuticals Stocks

1d 1w 1m 3m 6m 1y 3y 5y Max

* Results Consolidated

EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

ALEMBIC LTD Financials

No. of Mths Year Ending	12 Mar-14	12 Mar-15*	12 Mar-16*	12 Mar-17*	12 Mar-18*	5-Yr Chart Click to enlarge

ALEMBIC LTD EQUITY SHARE DATA
High	Rs	18	70	53	46	72
Low	Rs	7	16	29	32	34
Sales per share (Unadj.)	Rs	5.8	5.4	4.7	5.3	4.7
Earnings per share (Unadj.)	Rs	1.1	4.0	8.8	5.4	6.1
Diluted earnings per share	Rs	0.5	1.9	4.2	2.6	2.9
Cash flow per share (Unadj.)	Rs	1.2	4.2	9.0	5.6	6.2
Dividends per share (Unadj.)	Rs	0.15	0.15	0.15	0.20	0.20
Adj. dividends per share	Rs	0.07	0.07	0.07	0.10	0.10
Dividend yield (eoy)	%	1.2	0.3	0.4	0.5	0.4
Book value per share (Unadj.)	Rs	8.6	19.8	27.7	34.1	40.7
Adj. book value per share	Rs	4.2	9.5	13.4	16.5	19.6
Shares outstanding (eoy)	m	267.03	267.03	267.03	267.03	267.03
Bonus/Rights/Conversions		B1:1	-	-	-	-
Price / Sales ratio	x	2.1	8.0	8.7	7.5	11.3
Avg P/E ratio	x	11.2	10.8	4.7	7.2	8.7
P/CF ratio (eoy)	x	10.4	10.2	4.6	7.0	8.5
Price / Book Value ratio	x	1.4	2.2	1.5	1.2	1.3
Dividend payout	%	13.6	3.8	1.7	3.7	3.3
Avg Mkt Cap	Rs m	3,298	11,469	10,962	10,521	14,139
No. of employees	`000	NA	NA	NA	NA	NA
Total wages/salary	Rs m	273	270	238	228	207
Avg. sales/employee	Rs Th	NM	NM	NM	NM	NM
Avg. wages/employee	Rs Th	NM	NM	NM	NM	NM
Avg. net profit/employee	Rs Th	NM	NM	NM	NM	NM

ALEMBIC LTD INCOME DATA
Net Sales	Rs m	1,536	1,439	1,260	1,403	1,255
Other income	Rs m	158	208	264	310	370
Total revenues	Rs m	1,694	1,647	1,524	1,713	1,625
Gross profit	Rs m	223	95	83	67	111
Depreciation	Rs m	23	60	61	51	38
Interest	Rs m	23	8	0	2	2
Profit before tax	Rs m	335	235	285	324	442
Minority Interest	Rs m	0	0	0	0	0
Prior Period Items	Rs m	0	825	2,096	1,179	1,212
Extraordinary Inc (Exp)	Rs m	0	0	-32	-58	0
Tax	Rs m	39	-7	6	-9	24
Profit after tax	Rs m	295	1,066	2,343	1,454	1,630
Gross profit margin	%	14.5	6.6	6.6	4.8	8.9
Effective tax rate	%	11.8	-2.9	2.1	-2.6	5.4
Net profit margin	%	19.2	74.1	185.9	103.6	129.8

ALEMBIC LTD BALANCE SHEET DATA
Current assets	Rs m	1,543	1,609	1,689	1,913	1,867
Current liabilities	Rs m	907	533	486	683	591
Net working cap to sales	%	41.4	74.8	95.4	87.6	101.6
Current ratio	x	1.7	3.0	3.5	2.8	3.2
Inventory Days	Days	248	214	217	132	94
Debtors Days	Days	66	122	81	56	74
Net fixed assets	Rs m	1,800	1,715	1,624	1,716	1,791
Share capital	Rs m	534	534	534	534	534
"Free" reserves	Rs m	874	3,839	5,960	8,580	10,324
Net worth	Rs m	2,307	5,278	7,404	9,114	10,858
Long term debt	Rs m	331	354	104	18	41
Total assets	Rs m	3,562	6,192	8,010	9,924	11,591
Interest coverage	x	15.4	29.3	950.7	203.8	260.9
Debt to equity ratio	x	0.1	0.1	0	0	0
Sales to assets ratio	x	0.4	0.2	0.2	0.1	0.1
Return on assets	%	8.9	17.4	29.3	14.7	14.1
Return on equity	%	12.8	20.2	31.6	16.0	15.0
Return on capital	%	13.6	19.0	31.3	15.8	15.2
Exports to sales	%	7.7	14.3	2.9	0.7	1.5
Imports to sales	%	3.4	2.5	28.9	25.4	21.0
Exports (fob)	Rs m	118	205	37	10	19
Imports (cif)	Rs m	52	37	364	356	263
Fx inflow	Rs m	118	205	37	10	19
Fx outflow	Rs m	63	42	365	357	264
Net fx	Rs m	55	163	-328	-346	-244

ALEMBIC LTD CASH FLOW
From Operations	Rs m	-102	220	346	516	236
From Investments	Rs m	178	47	-48	-467	-224
From Financial Activity	Rs m	-79	-250	-301	-50	-27
Net Cashflow	Rs m	-3	17	-3	0	-15

* Results Consolidated

Source: Company Annual Reports, Regulatory Filings, Equitymaster

» Historical quarterly results for alembic limited

Share Holding

Indian Promoters	64.0%
Foreign collaborators	0.0%
Indian inst/Mut Fund	0.2%
FIIs	9.7%
ADR/GDR	0.0%
Free float	26.1%
Shareholders	54,701
Pledged promoter(s) holding	0.0%

Today's Market

US-China Trade Talks, Oil Prices, and Top Stocks in Action Today(Pre-Open)

On Tuesday, share markets in India witnessed selling pressure during closing hours and ended their trading session marginally lower after a volatile day of trading.

Views on news

ALEMBIC LTD Announces Quarterly Results (3QFY19); Net Profit Down 41.9% (Quarterly Result Update)

Feb 1, 2019 | Updated on Feb 1, 2019

For the quarter ended December 2018, ALEMBIC LTD has posted a net profit of Rs 32 m (down 41.9% YoY). Sales on the other hand came in at Rs 243 m (down 18.8% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

ALEMBIC LTD Announces Quarterly Results (2QFY19); Net Profit Up 4.0% (Quarterly Result Update)

Nov 12, 2018 | Updated on Nov 12, 2018

For the quarter ended September 2018, ALEMBIC LTD has posted a net profit of Rs 294 m (up 4.0% YoY). Sales on the other hand came in at Rs 336 m (up 3.1% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

The RCom Bankruptcy: 5 Lessons for Smallcap Investors(Profit Hunter)

Feb 7, 2019

Managements of companies can create or ruin their fortunes. Why is management quality such an important factor in valuing businesses? Read on to find out...

The One Real Estate Stock to Buy Now(The 5 Minute Wrapup)

Feb 13, 2019

The real estate sector is ready to make a comeback. This is the stock to consider buying.

How We Pick the Most Profitable Stocks from the Portfolios of Super Investors(The 5 Minute Wrapup)

Feb 8, 2019

This is the trick to following super investors and not losing money.

Small Caps Under Seige: Could This Be A Once-in-a-Decade Wealth Creating Opportunity?(Profit Hunter)

Feb 14, 2019

Don't let the dark clouds hovering over small caps scare you into hiding; it will rain gold as sentiments recover. Indeed, there is a blood bath. And if you are a first time investor, the correction is deep enough to scare you out of markets.

Don't Be Afraid of the Market; Buy Stocks Like This One(The 5 Minute Wrapup)

Feb 14, 2019

During this tough period in the market, a contrarian approach holds huge potential upside for this Smart Money Secrets stock.

Track your investment in ALEMBIC LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
Add To MyStocks

ALEMBIC LTD - ACTAVIS COMPARISON

Compare Company With Charts

COMPARE ALEMBIC LTD WITH

MARKET STATS

ABOUT EQUITYMASTER

Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.

FREE NEWSLETTERS

PREMIUM PRODUCTS

QUICK LINKS

APPS

FOLLOW

Follow @Equitymaster

Equitymaster Agora Research Private Limited (Research Analyst) 103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: info@equitymaster.com. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407

All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

LEGAL DISCLAIMER: Equitymaster Agora Research Private Limited (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.

SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

Testimonials